GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr | ₹0.41 Cr |
What is the latest Total Non-Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹0.00 Cr |
Mar2021 | ₹0.17 Cr |
Mar2020 | ₹0.41 Cr |
How is Total Non-Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | -19.60 | |
Mar2023 | ₹16 Cr | 538,266.67 | |
Mar2022 | ₹0.00 Cr | -98.21 | |
Mar2021 | ₹0.17 Cr | -59.42 | |
Mar2020 | ₹0.41 Cr | - |
Compare Total Non-Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹299.0 Cr | 3.1% | -5.3% | -31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,269.0 Cr | 1.6% | -8.2% | 4% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,381.0 Cr | 0.9% | -8.7% | 59.9% | Stock Analytics | |
CIPLA | ₹117,803.0 Cr | 3.6% | 1.5% | -0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,974.0 Cr | 3.8% | -1.4% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹94,527.1 Cr | 1.2% | -7.8% | -10.1% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 3.1% |
-5.3% |
-31.4% |
SENSEX | 1.6% |
-5.4% |
0.7% |
You may also like the below Video Courses